FI954245L - Compositions and methods for treating immune-mediated inflammatory disorders - Google Patents

Compositions and methods for treating immune-mediated inflammatory disorders Download PDF

Info

Publication number: FI954245L
Authority: FI; Finland
Prior art keywords: compositions; methods; inflammatory disorders; mediated inflammatory; treating immune
Prior art date: 1993-03-12

Application number

FI954245A

Other languages

Finnish (fi)

Swedish (sv)

Other versions

FI954245A0 (en

Inventor

Kerry Spear

Charles Johnson

Heinz W Gschwend

Original Assignee

Arris Pharm Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-03-12

Filing date

1995-09-11

Publication date

1995-09-28

1995-09-11 Application filed by Arris Pharm Corp filed Critical Arris Pharm Corp

1995-09-11 Publication of FI954245A0 publication Critical patent/FI954245A0/en

1995-09-28 Publication of FI954245L publication Critical patent/FI954245L/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
- C07K5/06095—Arg-amino acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

FI954245A 1993-03-12 1995-09-11 Compositions and methods for treating immune-mediated inflammatory disorders FI954245L (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US3077093A	1993-03-12	1993-03-12
US3118793A	1993-03-12	1993-03-12
PCT/US1994/002706 WO1994020527A1 (en)	1993-03-12	1994-03-11	Compositions and methods for the treatment of immunomediated inflammatory disorders

Publications (2)

Publication Number	Publication Date
FI954245A0 FI954245A0 (en)	1995-09-11
FI954245L true FI954245L (en)	1995-09-28

Family

ID=26706445

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI954245A FI954245L (en)	1993-03-12	1995-09-11	Compositions and methods for treating immune-mediated inflammatory disorders

Country Status (11)

Country	Link
EP (1)	EP0688337A1 (en)
JP (1)	JPH08507768A (en)
KR (1)	KR100309616B1 (en)
CN (2)	CN1057772C (en)
AU (1)	AU683459B2 (en)
CZ (1)	CZ289930B6 (en)
FI (1)	FI954245L (en)
PL (1)	PL176941B1 (en)
SK (1)	SK282537B6 (en)
UA (1)	UA42719C2 (en)
WO (1)	WO1994020527A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2764495A (en) *	1994-06-01	1995-12-21	Arris Pharmaceutical Corporation	Compositions and methods for treating mast-cell mediated conditions
CZ87097A3 (en) *	1994-09-23	1997-11-12	Arris Pharm Corp	Preparation for therapy and therapeutical methods for treating inflammations mediated by mast cells
WO1997037969A1 (en)	1996-04-10	1997-10-16	Ono Pharmaceutical Co., Ltd.	Tryptase inhibitor and novel guanidino derivatives
SK8599A3 (en) *	1996-07-30	2000-03-13	Arris Pharm Corp	Disubstituted cyclic compound, process for its preparation, pharmaceutical composition and method of the treatment of an animal
WO1998024886A1 (en) *	1996-12-04	1998-06-11	Brigham And Women's Hospital, Inc.	Mast cell protease that cleaves fibrinogen
WO1998033812A1 (en) *	1997-02-05	1998-08-06	Brigham And Women's Hospital, Inc.	Mast cell protease peptide inhibitors
US6221914B1 (en)	1997-11-10	2001-04-24	Array Biopharma Inc.	Sulfonamide bridging compounds that inhibit tryptase activity
AU1208999A (en) *	1997-11-10	1999-05-31	Array Biopharma, Inc.	Compounds which inhibit tryptase activity
AU1176299A (en) *	1997-11-26	1999-06-15	Yoshitomi Pharmaceutical Industries, Ltd.	Tryptase inhibitors comprising heterocyclic amide compounds
SE515982C2 (en) *	1998-03-06	2001-11-05	Lipocore Holding Ab	Use of an oil-in-water emulsion as carrier for preparing a topical cream or lotion
SE9800729L (en) *	1998-03-06	1999-09-07	Scotia Lipidteknik Ab	New topical formulation I
DE19939910A1 (en) *	1999-08-23	2001-03-01	Morphochem Ag	New compounds that inhibit tryptase activity
GB0507577D0 (en) *	2005-04-14	2005-05-18	Novartis Ag	Organic compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4201863A (en) *	1974-11-08	1980-05-06	Mitsubishi Chemical Industries, Limited	N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4456595A (en) *	1982-12-06	1984-06-26	E. R. Squibb & Sons, Inc.	Carboxy and substituted carboxy aroly peptides

1994
- 1994-03-11 JP JP6520352A patent/JPH08507768A/en not_active Ceased
- 1994-03-11 AU AU63647/94A patent/AU683459B2/en not_active Ceased
- 1994-03-11 KR KR1019950703932A patent/KR100309616B1/en not_active Expired - Fee Related
- 1994-03-11 WO PCT/US1994/002706 patent/WO1994020527A1/en not_active Application Discontinuation
- 1994-03-11 EP EP94910926A patent/EP0688337A1/en not_active Ceased
- 1994-03-11 PL PL94310559A patent/PL176941B1/en unknown
- 1994-03-11 CZ CZ19952321A patent/CZ289930B6/en not_active IP Right Cessation
- 1994-03-11 SK SK1129-95A patent/SK282537B6/en unknown
- 1994-03-11 CN CN94191441A patent/CN1057772C/en not_active Expired - Fee Related
- 1994-03-11 UA UA95104466A patent/UA42719C2/en unknown
1995
- 1995-09-11 FI FI954245A patent/FI954245L/en unknown
1998
- 1998-06-15 CN CN98102273A patent/CN1234229A/en active Pending

Also Published As

Publication number	Publication date
CZ289930B6 (en)	2002-04-17
PL310559A1 (en)	1995-12-27
CN1234229A (en)	1999-11-10
AU6364794A (en)	1994-09-26
CN1119019A (en)	1996-03-20
FI954245A0 (en)	1995-09-11
SK282537B6 (en)	2002-10-08
UA42719C2 (en)	2001-11-15
AU683459B2 (en)	1997-11-13
CN1057772C (en)	2000-10-25
PL176941B1 (en)	1999-08-31
WO1994020527A1 (en)	1994-09-15
CZ232195A3 (en)	1996-07-17
KR100309616B1 (en)	2002-02-28
EP0688337A1 (en)	1995-12-27
SK112995A3 (en)	1996-10-02
JPH08507768A (en)	1996-08-20

Publication	Publication Date	Title
KR950700732A (en)	1995-02-20	Compounds useful for treating allergic and inflammatory diseases
GR3036347T3 (en)	2001-11-30	Compounds useful for treating allergic and inflammatory diseases.
EP0634930A4 (en)	1995-02-22	Compounds useful for treating allergic and inflammatory diseases.
FI972781L (en)	1997-08-27	Methods and compositions for treating allergic rhinitis and other diseases using decarboethoxyloratadiene
FI940932L (en)	1994-02-28	Compositions and methods for treating wounds
FI971171L (en)	1997-03-20	Compositions and methods for treating mast cell-mediated inflammatory diseases
GR3036364T3 (en)	2001-11-30	Compositions and methods for treating or preventing inflammatory diseases
FI963692L (en)	1996-09-18	Methods and compositions useful for inhibiting angiogenesis
FI931738L (en)	1993-10-17	TEKNISK HARTS-PROPENEMYPOLYMER COMPOSITION
DE69325158D1 (en)	1999-07-08	Photocromic composition
FI953593L (en)	1995-07-27	G-CSF Analog Compositions and Methods
FI970522L (en)	1997-04-07	Compositions and methods for providing prolonged local anesthesia
BR9403948A (en)	1995-06-13	Composition of matter
FI974423L (en)	1998-02-04	Immunological Recombinant Compositions and Methods
FI932957L (en)	1993-12-25	GLASFIBERFOERSTAERKT PROPENYLPOLYMER COMPOSITION
FI951197L (en)	1995-03-15	Microbicidal compositions and methods
FI972433L (en)	1997-06-06	Rantes peptide and fragments and compositions containing the same suitable for treating inflammation
DK0565078T3 (en)	1998-10-07	Hardenable composition
FI970534L (en)	1997-02-07	Methods and compositions for preventing and treating endotoxin-related conditions
IS4466A (en)	1997-04-17	Composition and treatment for multiple sclerosis
FI954245A0 (en)	1995-09-11	Compositions and methods for treating immune-mediated inflammatory disorders
DE69320397D1 (en)	1998-09-24	Photopolymerizable composition
FI965008L (en)	1996-12-13	Compositions and methods for treating tumors
BR9510062A (en)	1998-06-02	Esterified macromonome and composition
DE69520998D1 (en)	2001-06-28	Fiber treatment compositions